Onkoras-101: A phase 1a/1b open-label study evaluating the safety, tolerability, pharmacokinetics, and efficacy of BBO-8520 in subjects with advanced KRASG12C mutant non-small-cell lung cancer. This ...
Forbes contributors publish independent expert analyses and insights. Curiosity expert improving engagement, innovation, and productivity. Workplaces today are more multigenerational than ever, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results